Combination of bortezomib and venetoclax targets the pro-survival function of LMP-1 and EBNA-3C of Epstein-Barr virus in post-transplant lymphoproliferative disorder
Kam Pui Tam, Jia Xie, Rex K.H. Au-Yeung, Aks Chiang
This paper shows that combining bortezomib and venetoclax kills PTLD cells by targeting EBV proteins LMP-1 and EBNA-3C through proteasome inhibition and Bcl-2 suppression.
bioRxiv · May 13, 2024 · PreprintMolecular Biology